Sulphasalazine: Mechanism of action in rheumatoid arthritis

被引:68
作者
Smedegard, G
Bjork, J
机构
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1995年 / 34卷
关键词
sulphasalazine; 5-aminosalicylic acid; sulphapyridine; pharmacology; rheumatoid arthritis; experimental models; immunomodulator;
D O I
10.1093/rheumatology/xxxiv.suppl_2.7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sulphasalazine a drug used for the treatment of rheumatoid arthritis (RA) shows a wide range of biological activities all of which might contribute to the beneficial clinical effect seen during treatment of RA. This review summarizes some of the biological activities and discusses these in context of possible modes of action of the drug. Sulphasalazine has been described as an antibacterial drug, an anti-inflammatory drug or as an immunomodulator. From the reviewed data it is concluded that the effects of sulphasalazine on various immunological processes, are of outstanding importance for its mode of action.
引用
收藏
页码:7 / 15
页数:9
相关论文
共 132 条
[1]  
ABE C, 1991, INT J IMMUNOTHER, V7, P9
[2]   THE MECHANISMS OF ACTION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ABRAMSON, SB ;
WEISSMANN, G .
ARTHRITIS AND RHEUMATISM, 1989, 32 (01) :1-9
[3]  
ALI ATMM, 1982, LANCET, V1, P506
[4]   A COMPARISON OF EFFECTS OF SULFASALAZINE AND ITS METABOLITES ON THE METABOLISM OF ENDOGENOUS VS EXOGENOUS ARACHIDONIC-ACID [J].
ALLGAYER, H ;
STENSON, WF .
IMMUNOPHARMACOLOGY, 1988, 15 (01) :39-46
[5]   INHIBITION OF CELL-MEDIATED CYTOTOXICITY BY SULFASALAZINE - EFFECT OF INVIVO TREATMENT WITH 5-AMINOSALICYLIC ACID AND SULFASALAZINE ON INVITRO NATURAL-KILLER-CELL ACTIVITY [J].
APARICIOPAGES, MN ;
VERSPAGET, HW ;
HAFKENSCHEID, JCM ;
CRAMABOHBOUTH, GE ;
PENA, AS ;
WETERMAN, IT ;
LAMERS, CBHW .
GUT, 1990, 31 (09) :1030-1032
[6]  
ASTBURY C, 1990, BRIT J RHEUMATOL, V29, P465
[7]   CO-TRIMOXAZOLE IN RHEUMATOID-ARTHRITIS - A COMPARISON WITH SULFAPYRIDINE [J].
ASTBURY, C ;
HILL, J ;
BIRD, HA .
ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (04) :323-327
[8]  
ASTBURY C, 1992, BRIT J RHEUMATOL, V31, P461
[9]  
AVAKIAN H, 1980, BRIT J EXP PATHOL, V61, P92
[10]  
AXELSSONLG, 1993, IMMUNOPHARMACOLOGY, V2, P219